Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

3.43
Delayed Data
As of Nov 17
 0.00 / 0.00%
Today’s Change
2.95
Today|||52-Week Range
5.66
-16.95%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues15.0M0.000.000.00
 
 
Depreciation And Amortization265.0K295.0K270.0K277.0K
 
 
 
 
 
 
Operating ExpensesGross Income---295.0K-270.0K-277.0K
 
 
 
 
General Expenses20.0M21.2M23.3M20.1M
 
 
 
 
 
Research And Development15.0M15.8M18.2M15.5M
 
 
 
 
 
Total Operating Expenses20.3M21.5M23.5M20.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.3M-21.5M-23.5M-20.4M
 
 
 
 
 
Interest Expense On Debt14.0K17.0K12.0K8.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.4M-20.5M-22.5M-19.2M
 
 
 
 
 
Income Taxes0.00-340.0K-75.0K-100.0K
 
 
 
 
Net Income-4.4M-20.2M-22.5M-19.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS136.7M136.7M136.7M137.4M
 
 
 
 
 
Shares To Calculate EPS Diluted136.7M136.7M136.7M137.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.03-$0.15-$0.16-$0.14
 
 
 
 
 
EPS Diluted-$0.03-$0.15-$0.16-$0.14